NASDAQ:YI - 111 Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $16.00
  • Forecasted Upside: 70.39 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$9.39
▲ +0.34 (3.76%)
1 month | 3 months | 12 months
Get New 111 Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for YI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for YI

Average Price Target: $16.00
▲ +70.39% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for 111 in the last 3 months. The average price target is $16.00, with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 70.39% upside from the last price of $9.39.

Buy

The current consensus among 1 investment analysts is to buy stock in 111.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/15/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated CoverageBuy$16.00High
10/8/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ OverweightHigh
(Data available from 6/21/2016 forward)

111

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; and Jianming Pharmaceutical Group. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Read More

Today's Range

Now: $9.39
Low: $8.95
High: $9.59

50 Day Range

MA: $10.52
Low: $8.93
High: $12.89

52 Week Range

Now: $9.39
Low: $5.20
High: $45.88

Volume

279,800 shs

Average Volume

850,223 shs

Market Capitalization

$776.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Frequently Asked Questions

What sell-side analysts currently cover shares of 111?

The following Wall Street research analysts have issued reports on 111 in the last twelve months: Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell.
View the latest analyst ratings for YI.

What is the current price target for 111?

1 Wall Street analysts have set twelve-month price targets for 111 in the last year. Their average twelve-month price target is $16.00, suggesting a possible upside of 70.4%. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell has the highest price target set, predicting YI will reach $16.00 in the next twelve months. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell has the lowest price target set, forecasting a price of $16.00 for 111 in the next year.
View the latest price targets for YI.

What is the current consensus analyst rating for 111?

111 currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe YI will outperform the market and that investors should add to their positions of 111.
View the latest ratings for YI.

What other companies compete with 111?

How do I contact 111's investor relations team?

111's physical mailing address is 3-5/F NO.295 ZUCHONGZHI ROAD PUDONG NEW AREA, SHANGHAI F4, 201203. The company's listed phone number is 862120536666. The official website for 111 is www.111.com.cn.